Search

everythinglearnresearchcommunity

for

Search:↓

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

The drug combination significantly reduced epileptic drop attacks in patients.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

A new mutation in the LIPH gene was found to cause a rare hair disorder in a Japanese boy.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

A woman lost all her hair after overdosing on divalproex, but it grew back while still on the medication.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

New drug uses show promise but need more research.

Ritlecitinib can help about 14,000 people with severe hair loss.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

A new genetic variant in the LIPH gene causes hair growth issues in a Chinese patient.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Ritlecitinib works well and is safe for treating alopecia areata.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

Stopping azathioprine led to full hair regrowth and recovery in 2.5 months.